OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics

OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD near real-time AI powered provider network (“network”) enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently.

Access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030¹. OneMedNet is positioned at the forefront by leveraging Palantir software to combine OneMedNet’s expansive provider network with Palantir’s advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform.

Under the multi-year agreement, Palantir’s Artificial Intelligence Platform—renowned for enabling enterprises to unify complex datasets and enabling real-time insights—integrates with OneMedNet’s network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases.

Palantir’s software will be used to advance OneMedNet’s mission to bring the most current data to life sciences organizations decreasing costs and time to market for novel healthcare solutions.

“We’re proud to provide the AI infrastructure for OneMedNet to accelerate the delivery of transformative healthcare solutions that will ultimately improve patient outcomes,” said Drew Goldstein, Co-Head of Healthcare at Palantir.

Aaron Green, President and CEO of OneMedNet, added, “Palantir’s AIP helps us revolutionize our ability to deliver high-quality, regulatory-compliant data at remarkable speed. This positions us to power breakthroughs in clinical research and AI-driven healthcare solutions.”

1. https://www.strategyand.pwc.com/de/en/industries/pharma-life-sciences/ ... 

Impact of Palantir’s Artificial Intelligence Platform

• Faster Data Discovery: Customer data inquiries fulfilled in minutes instead of days, boosting OneMedNet’s ability to win orders with speed and precision.
• Accurate Data Delivery: Customers will be able to create custom cohorts, ensuring every data element aligns with their fit-for-purpose needs and remains fully relevant to their studies.
• Conversational Search: A new AI-powered interface, enabled by Palantir’s AIP and LLMs, allows subscribers to search, modify and zero in on the data they need across vast datasets.
• Increased Productivity: Automation to improve OneMedNet’s efficiency and reduce costs, enabling scalable growth with improved margins.
• Healthcare Standards Integration: Palantir’s ontology, paired with SNOMED, HCPCS, ICD-10, and CPT codes, ensures interoperable data access for life sciences users.
• Anonymization: OneMedNet’s proprietary AI algorithms to operate at scale on Palantir’s advanced platform to securely de-identify clinical data, ensuring regulatory compliance and protecting against exposure of Protected Health Information (PHI).

OneMedNet’s Objectives